Shamburg News · 8-K filed Oct 6, 2026, 4:07 PM EDT
Bolt Biotherapeutics Amends Redwood City Lease, Accelerates Expiration to December 2027
BOLT · Bolt Biotherapeutics, Inc.
- Material agreement
- Materiality: medium
On October 1, 2026, Bolt Biotherapeutics entered into a Second Amendment to its Redwood City, California lease with HCP LS Redwood City LLC. The company paid the landlord $1.0 million, acknowledged the landlord may draw its existing $1.5 million letter of credit in full, and agreed to an accelerated lease expiration of December 31, 2027, or earlier upon a Corporate Transaction. Upon closing of a Corporate Transaction, the company will pay a $4.5 million termination payment.
Source: SEC EDGAR, Form 8-K, Item 1.01, accession 0001193125-26-415560.
Written from the filing by Shamburg Markets. Figures are as reported by the company.